Alzheimer’s Symptoms May Start Outside the Brain, New Research Suggests

“Motor deficits may be an earlier indication,” Research Professor Xiufang “Nadine” Guo said, highlighting findings that Alzheimer’s disease may involve symptoms developing outside the brain long before cognitive decline sets in.

ScienceDaily and EuropeSays reported that inherited mutations linked to the condition can directly disrupt nerves controlling muscle movement without involvement from the central nervous system.

The research, published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, stems from investigations led by James Hickman at the University of Central Florida’s Nanoscience Technology Center alongside scientists at Hesperos. Funded by the National Institute on Aging, the study utilized human cell systems to examine how familial Alzheimer’s mutations affect motor function.

Commonly characterized by memory loss and confusion, Alzheimer’s has long puzzled clinicians who observe physical symptoms like altered gait, poor balance, and coordination issues years prior to cognitive decline. To investigate whether these physical difficulties stem entirely from brain degeneration or direct peripheral nerve interference, the UCF team examined familial Alzheimer’s, a rare inherited form typically manifesting between ages 40 and 65.

Alzheimer’s may have early warning signs outside the brain
Photo: europesays.com

Experiments demonstrated that motor neurons carrying familial Alzheimer’s mutations disrupt neuromuscular connections even when isolated from the brain and spinal cord. Motor neurons transmit electrical signals telling muscles to contract; when these pathways fail, individuals experience reduced coordination and muscle fatigue.

“This is the first time it’s been demonstrated that deficits in the peripheral nervous system can arise directly from these mutations,” Hickman stated, as reported by ScienceDaily and EuropeSays.

To replicate these interactions without animal models, researchers employed human-on-a-chip technology developed through Hesperos. This microscale platform allowed scientists to combine healthy muscle cells with stem cell-derived motor neurons carrying familial Alzheimer’s mutations under controlled conditions.

By measuring how consistently nerve signals produced muscle contractions and how long those muscles sustained activity, the team evaluated nerve-to-muscle communication directly. Hickman noted the functional parallel to routine clinical examinations, explaining that when a physician tests a knee-jerk reflex, they are evaluating that exact connection.

Research Parameter Study Detail
Lead Institution University of Central Florida (UCF)
Technology Platform Human-on-a-Chip (Hesperos)
Primary Funding National Institute on Aging (NIH)
Target Disease Form Familial (Inherited) Alzheimer’s
Journal Publication Alzheimer’s & Dementia

The discovery suggests that current therapeutic approaches focused exclusively on the central nervous system may overlook critical pathologies occurring in peripheral tissues. Guo emphasized that preserving motor function through early detection could also support cognitive health, noting the established link between regular physical activity and brain well-being.

While the laboratory models confirm that Alzheimer’s mutations directly impair peripheral nerve-to-muscle communication independently of the brain, further clinical research remains necessary to establish the exact timeline of symptom manifestation in human patients, particularly those with the more common, non-familial forms of the disease.

  • Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association – University of Central Florida Nanoscience Technology Center Study
  • National Institute on Aging (NIA) – Research Grant and Funding Documentation
Photo of author

Priya Deshmukh - Senior Editor, Health

Priya Deshmukh Senior Editor, Health Deshmukh is a practicing physician and renowned medical journalist, honored for her investigative reporting on public health. She is dedicated to delivering accurate, evidence-based coverage on health, wellness, and medical innovations.

Venezuela Health Institute Warns of Fake Cifarcaina and Peptides

Japan Fair Trade Commission Raids Microsoft Over Cloud Antitrust Concerns